Sort
23,748 grants matching “melanoma”
MULTI-TRACER PET ASSESSMENT OF RESPONSE TO NOVEL TARGETED CHEMOTHERAPY
$299,900John M Hoffman · University Of Utah · R21 · FY2014 · CA
Core 2: Animal and Pharmacology
$299,875Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2017 · CA
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$299,849James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Immunoactivating Peptide AXT201 in Combination with Anti-PD-1 Antibody for Triple-Negative Breast Cancer
$299,815Niranjan B Pandey · Asclepix Therapeutics, Inc. · R43 · FY2019 · CA
PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES
$299,811University Of Virginia Charlottesville · R01 · FY2001 · CA
Liver Specific Manganese Based MRI Contrast Agent
$299,811Vera Hoffman · Reveal Pharma · R44 · FY2019 · CA
Eastern Cooperative Oncology Group
$299,793Indiana Univ-Purdue Univ At Indianapolis · U10 · FY2004 · CA
Host's Genes that Control Lymphocyte Infiltration of Tumors
$299,776Peter Demant · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Mechanistic Studies on New Platinum Clinical Agents
$299,758Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2010 · CA
Novel diagnostics for autoimmunity from checkpoint inhibitor immune therapy
$299,754Sahar Usmani-Brown · L2 Diagnostics, Llc · R43 · FY2017 · DK
Dissecting the opposing roles of alpha-3 integrin in metastasis
$299,721Christopher S. Stipp · University Of Iowa · R01 · FY2011 · CA
Regulation of PTEN Activity in Cancer Cells
$299,712University Of Arizona · R01 · FY2004 · CA
TCR Affinity and Therapeutic Efficacy of T Cells
$299,698Michael I Nishimura · Medical University Of South Carolina · R01 · FY2009 · CA
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
$299,690Patricia Yotnda · Baylor College Of Medicine · R01 · FY2014 · CA
Dissecting the opposing roles of alpha-3 integrin in metastasis
$299,655Christopher S. Stipp · University Of Iowa · R01 · FY2012 · CA
Use of aAPC for Melanoma Adoptive Immunotherapy
$299,653Jonathan P Schneck · Johns Hopkins University · R01 · FY2013 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$299,639Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Personalized melanoma chemoprevention
$299,638Douglas Grossman · University Of Utah · R01 · FY2013 · CA
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
$299,607Emmanuel T Akporiaye · Veana Therapeutics, Llc · R43 · FY2018 · CA
Characterization of Tumor Specific T Cells in Melanoma
$299,564Stanford University · R01 · FY2002 · CA
Pathways from genotype and environment to melanoma
$299,523Nicholas K Hayward · Queensland Institute Of Medical Research · R01 · FY2009 · CA
Association of Inherited Variation in Immune Mediated Adverse Events and Respons
$299,473Katherine L Nathanson · Wistar Institute · P50 · FY2015 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$299,472Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2019 · CA
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo
$299,359Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA
A role for c-Abl/Arg in melanoma progression
$299,345Rina Plattner · University Of Kentucky · R01 · FY2014 · CA